Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Johnsson

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Neurology|April 17, 2026
Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple SclerosisIgal Rosenstein, Markus Axelsson, Magnus Johnsson, et al.
Journal of Neurology|April 7, 2026
Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 monthsNina Gleisner, Francisco Meda, Magnus Johnsson, et al.
Brain Communications|May 14, 2026
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosisChristina N Heiss, Lenka Novakova, Markus Axelsson, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Neurology|April 17, 2026
Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple SclerosisIgal Rosenstein, Markus Axelsson, Magnus Johnsson, et al.
Journal of Neurology|April 7, 2026
Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 monthsNina Gleisner, Francisco Meda, Magnus Johnsson, et al.
Brain Communications|May 14, 2026
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosisChristina N Heiss, Lenka Novakova, Markus Axelsson, et al.
Pageof 2